FindOwnerSearch
Brands and Their Owners
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| DITHIOCHROME | Thymax, Inc. | 1933 Davis Street San Leandro CA 94577 | chemical and pharmaceutical preparations for treating diabetes; and bioassay reagents for medical purposes;Dithio-Chrome; |
| KEDRION | KEDRION S.p.A. | Località Ai Conti, Castelvecchio Pascoli Barga (Lucca) 55051 Italy | Chemical pharmaceutical preparations, namely, laxatives, vitamins, antithrombotic agents, antimicrobials for dermatologic use; antiseptics; antibacterial pharmaceuticals for systemic purposes, pharmaceutical immunostimulants, analgesics, ophthalmological preparations, nutritional supplements; biological blood derivates, namely, plasma proteins, and antibacterial and antiviral vaccines derived naturally or from biotechnology;Business management of therapeutical centers, in particular plasma collection centers and blood banks;Medical services, namely, providing advice, management and counseling in medical matters; medical services, namely, disease management programs; |
| LUX | BIOTRONIK AG | Ackerstrasse 6 Bülach 8180 Switzerland | Chemical and pharmaceutical preparations for medical purposes, namely, drug preparations for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; chemical and pharmaceutical drug delivery preparations in the form of coatings for medical devices and balloons that facilitate the delivery of pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, drug preparations for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; pharmaceutical preparations for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; drugs for medical purposes, namely, drugs for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; excipients, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for use in drug eluting balloons;Medical apparatus and instruments, namely, catheters, catheters for percutaneous coronary intervention (PCI), catheters for percutaneous transluminal coronary angioplasty (PTCA catheters), catheters for percutaneous transluminal angioplasty (PTA catheters), catheters for balloon dilatation; medical apparatus, namely, balloons for vessel dilatation, balloons for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation, coronary and peripheral balloon catheters, drug eluting balloons, drug releasing balloons, drug coated balloons, stents and drug eluting stents; |
| MAGMARIS | BIOTRONIK AG | Ackerstrasse 6 Bülach 8180 Switzerland | Chemical and pharmaceutical preparations for medical use, namely, for treatment of vascular and cardiovascular diseases; organic and inorganic chemical and pharmaceutical preparations, namely, for treatment of vascular and cardiovascular diseases; chemical and pharmaceutical preparations for medical use, namely, inorganic preparations for the treatment of vascular and cardiovascular diseases; pharmaceutical preparations used in medical engineering, namely, drug delivery agents in the form of coatings for medical apparatus that facilitate the delivery of a wide range of active pharmaceutical ingredients; pharmaceuticals preparations, namely, drug delivery agents in form of coatings for stents and implants containing active pharmaceutical ingredients; chemical preparations for pharmaceutical or medical purposes, namely, drug delivery agents for enhancing the biocompatibility of implants in the form of coatings for stents; chemical preparations for pharmaceutical or medical purposes, namely, drug delivery agents for enhancing the healing of implants in the form of coatings for stents; medicines for the treatment of vascular and cardiovascular diseases; medical preparations for the treatment of vascular and cardiovascular diseases; medicines for the treatment of vascular and cardiovascular diseases; medicines and medicine preparations for the treatment of heart disease;The word(s) MAGMARIS has no meaning in a foreign language.;Surgical and medical apparatus and instruments, namely, vascular and cardiovascular implants and apparatus; stents, catheters, flexible stents, stents containing the active ingredients, Drug Eluting Stents (DES), absorbable stents, metal stents, Bare Metal Stents (BMS); coronary stents, namely, implantable absorbable scaffolds comprising artificial materials for maintaining tissue contour; implantable scaffolds comprising artificial materials for maintaining tissue contour and also containing an active pharmaceutical ingredient; implantable metal coronary scaffolds for maintaining tissue contour; |
| NEXRETYS | EVIVE BIOTECHNOLOGY (SHANGHAI) LTD. | 3 / F, BUILDING 1, 400 FANG CHUN ROAD CHINA (SHANGHAI) PILOT FREE TRADE ZONE SHANGHAI 201203 China | Chemical pharmaceutical preparations in the nature of chemical preparations for pharmaceutical purposes for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; human medicines for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; biochemical drugs for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; pharmaceutical preparations for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medicinal capsules for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical chemical preparations in the nature of chemical preparations for medical purposes for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical biological preparations for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical ointments, namely, medicated ointments for treating or preventing inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical drugs for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical diagnostic preparations; |
| ORSIRO | BIOTRONIK AG | Ackerstrasse 6 Bülach 8180 Switzerland | [ Chemical and pharmaceutical preparations for medical use, namely, medicated polymer-based preparations, including limus preparations of polyester, polylactic limus preparations and inorganic preparations for the treatment of cardiovascular and vascular diseases; chemical and pharmaceutical preparations for medical use for improving the biocompatibility of implants, namely, the coating of stents; chemical and pharmaceutical preparations for medical use for improving the healing of implants, namely, medicated stents; chemical products for pharmaceutical use, namely, medicated polymer-based preparations for the treatment of cardiovascular and vascular diseases; chemical and pharmaceutical preparations for cardiovascular and vascular procedures; drugs for medical use, namely, medicines belonging to the family of limus, namely, derivatives of limus, sirolimus, rapamycin, everolimus, biolimus A9, zotarolimus, tacrolimus and pimecrolimus for the treatment of cardiovascular and vascular diseases; medicines for human use for use in cardiovascular and vascular procedures ];The word(s) ORSIRO has no meaning in a foreign language.;Surgical and medical apparatus and instruments, namely, vascular and cardiovascular implants consisting of artificial materials and surgical instruments; catheters; catheters for percutaneous transluminal coronary angioplasty (PTCA catheters) and catheters for percutaneous translumial angioplasty (PTA catheters), namely, balloon dilatation catheters; medical apparatus and instruments, namely, balloon catheters and stents; stents which can expand by means of balloons; [ self-expanding stents; ] drug-eluting stents [ ; absorbable stents; absorbable drug-eluting stents ]; |
| PANTERA | BIOTRONIK AG | Ackerstrasse 6 Bülach 8180 Switzerland | chemical and pharmaceutical preparations for medical purposes, namely, excipient-drug preparations for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation; chemical and pharmaceutical drug delivery preparations in the form of coatings for medical devices and balloons that facilitate the delivery of pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, excipient-drug preparations and polymer drug preparations and polymer preparations for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation; chemico pharmaceutical preparations for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation; drugs for medical purposes, namely, drugs for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation; surgical implants comprising living tissues; medicines for human purposes, namely, for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation; and excipients for use in drug-eluting balloons in the nature of medical preparations for treating vascular and cardiovascular diseases;The English translation of PANTERA in the mark is panther.; |
| THIOCHROME | Thymax, Inc. | 1933 Davis Street San Leandro CA 94577 | chemical and pharmaceutical preparations for treating diabetes; and bioassay reagents for medical purposes;Thio-Chrome; |
| TIZUREST | EVIVE BIOTECHNOLOGY (SHANGHAI) LTD. | 3 / F, BUILDING 1, 400 FANG CHUN ROAD CHINA (SHANGHAI) PILOT FREE TRADE ZONE SHANGHAI 201203 China | Chemical pharmaceutical preparations in the nature of chemical preparations for pharmaceutical purposes for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; human medicines for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; biochemical drugs for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; pharmaceutical preparations for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medicinal capsules for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical chemical preparations in the nature of chemical preparations for medical purposes for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical biological preparations for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical ointments, namely, medicated ointments for treating or preventing inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical drugs for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical diagnostic preparations; |
| VIDON | Sanochemia Pharmazeutika AG | Boltzmanngasse 11 A-1090 Wien Austria | Chemical pharmaceutical preparations for the treatment and diagnosis of non muscle invasive bladder cancer;Color is not claimed as a feature of the mark.; |
Where the owner name is not linked, that owner no longer owns the brand |